DE60006113D1 - Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten - Google Patents

Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten

Info

Publication number
DE60006113D1
DE60006113D1 DE60006113T DE60006113T DE60006113D1 DE 60006113 D1 DE60006113 D1 DE 60006113D1 DE 60006113 T DE60006113 T DE 60006113T DE 60006113 T DE60006113 T DE 60006113T DE 60006113 D1 DE60006113 D1 DE 60006113D1
Authority
DE
Germany
Prior art keywords
preparing
pharmaceutical compositions
compositions containing
benzol derivatives
benzol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006113T
Other languages
English (en)
Other versions
DE60006113T2 (de
Inventor
Robert Boigegrain
Bernard Bourrie
Martine Bourrie
Pierre Casellas
Marc Herbert
Pierre Lair
Dino Nisato
Raymond Paul
Claude Vernieres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE60006113D1 publication Critical patent/DE60006113D1/de
Application granted granted Critical
Publication of DE60006113T2 publication Critical patent/DE60006113T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE60006113T 1999-06-11 2000-06-08 Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten Expired - Lifetime DE60006113T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9907396A FR2794742B1 (fr) 1999-06-11 1999-06-11 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
FR9907396 1999-06-11
PCT/FR2000/001575 WO2000076953A1 (fr) 1999-06-11 2000-06-08 Derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
DE60006113D1 true DE60006113D1 (de) 2003-11-27
DE60006113T2 DE60006113T2 (de) 2004-07-15

Family

ID=9546664

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006113T Expired - Lifetime DE60006113T2 (de) 1999-06-11 2000-06-08 Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten

Country Status (33)

Country Link
US (1) US6482986B1 (de)
EP (1) EP1192122B1 (de)
JP (1) JP4711579B2 (de)
KR (1) KR100668581B1 (de)
CN (1) CN1210250C (de)
AR (1) AR033793A1 (de)
AT (1) ATE252542T1 (de)
AU (1) AU768420B2 (de)
BR (1) BR0011738A (de)
CA (1) CA2374631C (de)
CO (1) CO5180554A1 (de)
CZ (1) CZ299659B6 (de)
DE (1) DE60006113T2 (de)
DK (1) DK1192122T3 (de)
ES (1) ES2208345T3 (de)
FR (1) FR2794742B1 (de)
HK (1) HK1042891B (de)
HU (1) HU228683B1 (de)
IL (1) IL146545A0 (de)
MX (1) MXPA01012783A (de)
NO (1) NO327778B1 (de)
NZ (1) NZ515529A (de)
PL (1) PL196491B1 (de)
PT (1) PT1192122E (de)
RS (1) RS49998B (de)
RU (1) RU2248964C2 (de)
SI (1) SI1192122T1 (de)
SK (1) SK286390B6 (de)
TW (1) TWI279398B (de)
UA (1) UA71959C2 (de)
UY (1) UY26199A1 (de)
WO (1) WO2000076953A1 (de)
ZA (1) ZA200109486B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
GB2410947B (en) * 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
EP1634598A1 (de) * 2004-09-07 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Verwendung von Piperazinderivaten und Analogen zur Behandlung oder Prophylaxe von Essstörungen
CN101184732B (zh) 2005-03-28 2012-05-16 株式会社半导体能源研究所 蒽衍生物、发光元件用材料、发光元件、发光装置和电子器件
FR2887454B1 (fr) * 2005-06-28 2009-06-05 Sanofi Aventis Sa Combinaisons antitumorales contenant des derives du taxane et des sigma ligands
GB0514501D0 (en) * 2005-07-14 2005-08-24 Cambridge Lab Ireland Ltd Pharmaceutical compounds
GB0516168D0 (en) * 2005-08-05 2005-09-14 Cambridge Lab Ireland Ltd Pharmaceutical compounds
US7731377B2 (en) * 2006-03-21 2010-06-08 Semiconductor Energy Laboratory Co., Ltd. Backlight device and display device
CN101506163B (zh) * 2006-08-30 2012-05-02 株式会社半导体能源研究所 合成蒽衍生物的方法和蒽衍生物、发光元件、发光装置、电子装置
GR1005865B (el) * 2007-01-17 2008-04-07 Anavex Life Sciences Corp. Νεοι συνδετες των σιγμα υποδοχεων με αντι-αποπτωτικες και/η προ-αποπτωτικες ιδιοτητες επι των κυτταρικων βιοχημικων μηχανισμων, με νευρο-προστατευτικη, αντικαρκινικη, αντι-μεταστατικη και αντι- αντι-(χρονιο)φλεγμονικη δραση.
US7723722B2 (en) 2007-03-23 2010-05-25 Semiconductor Energy Laboratory Co., Ltd. Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
FR2915994B1 (fr) * 2007-05-11 2009-07-03 Galderma Res & Dev Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl] -2-methoxy-acrylique.
US20080286445A1 (en) * 2007-05-17 2008-11-20 Semiconductor Energy Laboratory Co., Ltd. Composition, and method of fabricating light-emitting element
GB0810857D0 (en) * 2008-06-13 2008-07-23 Cambridge Lab Ireland Ltd Pharmaceutical compounds
CN102089282A (zh) * 2008-07-08 2011-06-08 株式会社半导体能源研究所 咔唑衍生物、发光元件用材料、发光元件以及发光装置
US20110053866A1 (en) * 2008-08-12 2011-03-03 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions
GB2462611A (en) * 2008-08-12 2010-02-17 Cambridge Lab Pharmaceutical composition comprising tetrabenazine
GB2463452A (en) * 2008-09-08 2010-03-17 Cambridge Lab Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
GB2463451A (en) * 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
GB2463283A (en) * 2008-09-08 2010-03-10 Cambridge Lab 3,11b-cis-dihydrotetrabenazine for use in treating asthma
EP2166001B1 (de) * 2008-09-19 2011-07-20 Semiconductor Energy Laboratory Co., Ltd. Carbazolderivat und Herstellungsverfahren dafür
WO2010059711A1 (en) * 2008-11-18 2010-05-27 Wisconsin Alumni Research Foundation Sigma-1 receptor ligands and methods of use
GR1006794B (el) 2009-02-26 2010-06-04 Αλεξανδρος Βαμβακιδης Προσδετες των σιγμα υποδοχεων, αντι-αποπτωτικες και προ-αποπτωτικες ιδιοτητες επι των κυτταρικων μηχανισμων, και με πρωτοτυπη κυτταρο-προστατευτικη αλλα και αντικαρκινικη δραση
KR102225715B1 (ko) * 2013-07-09 2021-03-09 토소가부시키가이샤 아다만틸기를 가진 환상 아진 화합물, 제조 방법, 및 상기 화합물을 구성 성분으로서 함유하는 유기 전계발광소자
KR20170101128A (ko) 2016-02-26 2017-09-05 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
WO2018022904A2 (en) 2016-07-27 2018-02-01 Case Western Reserve University Compounds and methods of promoting myelination
US10918610B2 (en) 2017-12-22 2021-02-16 Case Western Reserve University Compounds and methods of promoting myelination
WO2019126759A1 (en) * 2017-12-22 2019-06-27 Convelo Therapeutics, Inc. Compounds and methods of promoting myelination
EP4392487A1 (de) * 2021-08-23 2024-07-03 Marquette University Synthese und bewertung neuer (4-hydroxyphenyl) substituierter carbozyklen als wirksame und selektive östrogenrezeptor-betaagonisten

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
FR2641276B1 (fr) * 1988-12-30 1991-07-12 Sanofi Sa Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant
ZA909902B (en) * 1989-12-21 1991-10-30 Himont Inc Graft copolymers of polyolefins and a method of producing same
CA2071897A1 (en) * 1989-12-28 1991-06-29 Richard A. Glennon Sigma receptor ligands and the use thereof
FR2663328B1 (fr) 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
AU676993B2 (en) * 1991-06-27 1997-04-10 Virginia Commonwealth University Sigma receptor ligands and the use thereof
US5449639A (en) 1994-10-24 1995-09-12 Taiwan Semiconductor Manufacturing Company Ltd. Disposable metal anti-reflection coating process used together with metal dry/wet etch
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales

Also Published As

Publication number Publication date
ATE252542T1 (de) 2003-11-15
FR2794742A1 (fr) 2000-12-15
RS49998B (sr) 2008-09-29
KR20020009632A (ko) 2002-02-01
MXPA01012783A (es) 2002-09-18
SI1192122T1 (en) 2004-04-30
CZ20014443A3 (cs) 2002-05-15
NO327778B1 (no) 2009-09-21
CN1210250C (zh) 2005-07-13
US6482986B1 (en) 2002-11-19
CZ299659B6 (cs) 2008-10-08
PL352742A1 (en) 2003-09-08
HK1042891B (zh) 2004-04-08
CN1355782A (zh) 2002-06-26
DK1192122T3 (da) 2004-03-01
IL146545A0 (en) 2002-07-25
HK1042891A1 (en) 2002-08-30
ES2208345T3 (es) 2004-06-16
AR033793A1 (es) 2004-01-07
CA2374631C (en) 2010-10-19
EP1192122B1 (de) 2003-10-22
CA2374631A1 (en) 2000-12-21
NO20016038L (no) 2002-02-11
NZ515529A (en) 2004-01-30
NO20016038D0 (no) 2001-12-10
JP2003502306A (ja) 2003-01-21
YU87101A (sh) 2004-07-15
AU5539600A (en) 2001-01-02
SK18062001A3 (sk) 2002-05-09
HU228683B1 (en) 2013-05-28
PT1192122E (pt) 2004-03-31
SK286390B6 (sk) 2008-09-05
JP4711579B2 (ja) 2011-06-29
CO5180554A1 (es) 2002-07-30
EP1192122A1 (de) 2002-04-03
HUP0201953A2 (hu) 2002-12-28
UY26199A1 (es) 2001-01-31
UA71959C2 (en) 2005-01-17
RU2248964C2 (ru) 2005-03-27
FR2794742B1 (fr) 2005-06-03
BR0011738A (pt) 2002-03-05
TWI279398B (en) 2007-04-21
AU768420B2 (en) 2003-12-11
PL196491B1 (pl) 2008-01-31
HUP0201953A3 (en) 2006-03-28
DE60006113T2 (de) 2004-07-15
WO2000076953A1 (fr) 2000-12-21
KR100668581B1 (ko) 2007-01-17
ZA200109486B (en) 2002-11-18

Similar Documents

Publication Publication Date Title
DE60006113D1 (de) Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69634806D1 (de) Substituierte heterocyclische Verbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE69902535T2 (de) Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen
DE59610280D1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE317688T1 (de) Orale pharmazeutische zusammensetzung enthaltend ein benzimidazolderivat mit antiulcus wirkung und verfahren zu seiner herstellung
DE59611204D1 (de) Arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE219069T1 (de) Neue arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE323092T1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE60307875D1 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
ATE143010T1 (de) Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE60110278D1 (de) 4-Sulfonamid-Piperidin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
ATE222586T1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE353321T1 (de) Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahren,ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
DE60300571D1 (de) [3,4-a:3,4-c]Carbazolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE69808793D1 (de) Pharmazeutische zusammensetzungen aus dalfopristine und quinupristine und verfahren zu ihrer herstellung
ATE244246T1 (de) Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE289595T1 (de) Neue pyrimidin-2,4,6-trion-derivate, verfahren zu ihrer herstellung und pharmazeutische mittel die diese enthalten
DE60200041D1 (de) Indenoindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltenden pharmazeutischen Zusammensetzungen
DE69931038D1 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
DE60200023D1 (de) Isoindoloindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltende pharmazeutische Zusammensetzungen
DE60000646D1 (de) Pyrrolo[3,4-b]chinolinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE60222515D1 (de) BenzoÄbÜpyranoÄ3,2-hÜacridin-7-on Derivative, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE60007168D1 (de) Benzopyranyl-guanidin-derivate, verfahren zu deren herstellung sowie diese enthaltenden pharmazeutische zusammensetzungen
DE69107274D1 (de) Phenoxyessigsäure-Derivate, Verfahren zu ihrer Herstellung, und pharmazeutische Zusammensetzungen die sie enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

R082 Change of representative

Ref document number: 1192122

Country of ref document: EP

Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE